| Date Filed | Type | Description |
| 10/04/2023 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 10/04/2023 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 10/04/2023 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 10/04/2023 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 10/04/2023 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 10/04/2023 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 10/04/2023 |
8-K
| Acquisition/merger/asset purchase announced|
Docs:
|
"AGREEMENT AND PLAN OF MERGER among SOMALOGIC, INC., STANDARD BIOTOOLS INC., and MARTIS MERGER SUB, INC.",
"Standard BioTools and SomaLogic to Combine in All-Stock Merger Creating a Diversified Leader in Life Sciences Tools",
"Investor Presentation",
"Form of Standard BioTools Inc. Voting Agreement for Series B-2 Preferred Stockholders",
"Form of Standard BioTools Inc. Voting Agreement for Directors and Officers",
"Form of SomaLogic, Inc. Voting Agreement" |
|
| 08/23/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/11/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/08/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/08/2023 |
8-K
| Quarterly results |
| 07/28/2023 |
8-K
| Quarterly results |
| 07/07/2023 |
SC 13G/A
| PRIMECAP MANAGEMENT CO reports a 4.1% stake in Standard BioTools Inc. |
| 07/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 06/16/2023 |
4
| Madaus Martin D (Director) has filed a Form 4 on STANDARD BIOTOOLS INC.|
Txns:
| Granted 26,376 shares
@ $0
Granted 35,380 options to buy
@ $2.18, valued at
$77.1k
|
|
| 06/16/2023 |
4
| Casdin Eli (Director) has filed a Form 4 on STANDARD BIOTOOLS INC.|
Txns:
| Granted 26,376 shares
@ $0
Granted 35,380 options to buy
@ $2.18, valued at
$77.1k
|
|
| 06/16/2023 |
4
| Witney Frank (Director) has filed a Form 4 on STANDARD BIOTOOLS INC.|
Txns:
| Granted 26,376 shares
@ $0
Granted 35,380 options to buy
@ $2.18, valued at
$77.1k
|
|
| 06/16/2023 |
4
| Paya Carlos V (Director) has filed a Form 4 on STANDARD BIOTOOLS INC.|
Txns:
| Granted 26,376 shares
@ $0
Granted 35,380 options to buy
@ $2.18, valued at
$77.1k
|
|
| 06/16/2023 |
4
| Clague Laura (Director) has filed a Form 4 on STANDARD BIOTOOLS INC.|
Txns:
| Granted 26,376 shares
@ $0
Granted 35,380 options to buy
@ $2.18, valued at
$77.1k
|
|
| 06/16/2023 |
4
| ELOI FENEL M (Director) has filed a Form 4 on STANDARD BIOTOOLS INC.|
Txns:
| Granted 26,376 shares
@ $0
Granted 35,380 options to buy
@ $2.18, valued at
$77.1k
|
|
| 06/16/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 05/26/2023 |
SD
| Form SD - Specialized disclosure report: |
| 05/22/2023 |
4
| Black Jeffrey G. (SVP & CFO) has filed a Form 4 on STANDARD BIOTOOLS INC.|
Txns:
| Bought 43,492 shares
@ $2.2157, valued at
$96.4k
Bought 42,492 shares
@ $2.2878, valued at
$97.2k
|
|
| 05/19/2023 |
4
| Casdin Eli (10% Owner) has filed a Form 4 on STANDARD BIOTOOLS INC.|
Txns:
| Bought 250,000 shares
@ $1.8862, valued at
$471.6k
Bought 150,000 shares
@ $2.1591, valued at
$323.9k
Bought 800,000 shares
@ $2.2949, valued at
$1.8M
|
|
| 05/19/2023 |
4
| Casdin Partners Master Fund, L.P. (10% Owner) has filed a Form 4 on STANDARD BIOTOOLS INC.|
Txns:
| Bought 250,000 shares
@ $1.8862, valued at
$471.6k
Bought 150,000 shares
@ $2.1591, valued at
$323.9k
Bought 800,000 shares
@ $2.2949, valued at
$1.8M
|
|
| 05/19/2023 |
3
| Casdin Partners FO1-MSV, LP (Director) has filed a Form 3 on STANDARD BIOTOOLS INC. |
| 05/17/2023 |
4
| Black Jeffrey G. (SVP & CFO) has filed a Form 4 on STANDARD BIOTOOLS INC.|
Txns:
| Granted 210,526 restricted stock units
@ $0
Granted 400,000 options to buy
@ $1.9, valued at
$760k
|
|
| 05/17/2023 |
3
| Black Jeffrey G. (SVP & CFO) has filed a Form 3 on STANDARD BIOTOOLS INC. |
| 05/15/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...|
Docs:
|
"Appendix A Standard BioTools Inc. 2020 Change of Control and Severance Plan Participation Agreement",
"STANDARD BIOTOOLS INC.",
"Available Information Standard BioTools uses its website , investor site , corporate Twitter account , Facebook page , and LinkedIn page as channels of distribution of information about its products, its planned financial and other announcements, its attendance at upcoming investor and industry conferences, and other matters. Such information may be deemed material information, and Standard BioTools may use these channels to comply with its disclosure obligations under Regulation FD. Therefore, investors should monitor Standard BioTools’ website and its social media accounts in addition to following its press releases, SEC filings, public conference calls, and webcasts." |
|
| 05/09/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/09/2023 |
8-K
| Quarterly results |
| 05/03/2023 |
8-K
| Quarterly results |
|